Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001239948 | SCV001412857 | uncertain significance | Methylmalonic aciduria and homocystinuria type cblD | 2024-11-05 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 186 of the MMADHC protein (p.Met186Thr). This variant is present in population databases (rs61755260, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with MMADHC-related conditions. ClinVar contains an entry for this variant (Variation ID: 965486). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt MMADHC protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV001239948 | SCV003808858 | uncertain significance | Methylmalonic aciduria and homocystinuria type cblD | 2022-04-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004034632 | SCV005008721 | uncertain significance | Inborn genetic diseases | 2022-04-22 | criteria provided, single submitter | clinical testing | The c.557T>C (p.M186T) alteration is located in exon 6 (coding exon 5) of the MMADHC gene. This alteration results from a T to C substitution at nucleotide position 557, causing the methionine (M) at amino acid position 186 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001239948 | SCV002083917 | uncertain significance | Methylmalonic aciduria and homocystinuria type cblD | 2020-02-13 | no assertion criteria provided | clinical testing |